
Stimuli-Responsive Hydrogels for Ophthalmic Drug Delivery
- 1st Edition - May 8, 2024
- Imprint: Woodhead Publishing
- Authors: Dipankar Chattopadhyay, Jonathan Tersur Orasugh, Anjan Adhikari, Suprakas Sinha Ray
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 9 1 5 6 - 8
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 9 3 5 9 - 3
Stimuli-Responsive Hydrogels for Ophthalmic Drug Delivery covers fundamental aspects in the preparation of polymeric in-situ, stimuli-responsive hydrogels, including propertie… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteStimuli-Responsive Hydrogels for Ophthalmic Drug Delivery covers fundamental aspects in the preparation of polymeric in-situ, stimuli-responsive hydrogels, including properties, characterization, chemistry, and fabrication of these hydrogels. The book will help the reader select the most appropriate material and design for the desired application. The book goes on to review applications in ophthalmic drug delivery, covering in vitro and in vivo models, animal models, preclinical testing, patents, and more. This is a must-have reference for researchers and academics in the fields of materials science, biomaterials, pharmacology and polymer science, with an interest in clinical aspects of hydrogel design and application.
- Provides step-by-step coverage for engineering in-situ and stimuli-responsive hydrogels, from design, characterization, and toxicity considerations to fabrication, process optimization, and drug release kinetics
- Utilizes an interdisciplinary approach, bringing together authors from pharmacology, polymer science, and medical backgrounds
- Details the advantages and challenges of using stimuli-responsive hydrogels for ophthalmic drug delivery, with a focus on clinical translation
Researchers and postgraduate students in the fields of materials science/biomaterials, biomedical engineering, pharmacology, and tissue engineering
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Preface
- Part I. Preparation and properties of in situ hydrogel-based biomaterial: Ophthalmic drug delivery
- Chapter 1. Introduction
- 1.1. Introduction
- 1.2. Convincing adoptive usage of OP-based in situ forming hydrogel systems
- 1.3. Conclusions and future prospects
- Chapter 2. Introduction to polymeric in situ forming hydrogels for ophthalmic drug delivery
- 2.1. Introduction
- 2.2. Stimuli-responsive in situ gelling hydrogels
- 2.3. Low-molecular-weight polymeric hydrogels
- 2.4. Cyclodextrin/poly(ethylene glycol)–based polymeric hydrogels
- 2.5. In situ forming hydrogel-based microneedles
- 2.6. Clinical trials and proven marketed stimuli-responsive hydrogels-based ophthalmic formulations
- 2.7. Recent advancements and emerging trends
- 2.8. Challenges and innovations
- 2.9. Conclusions and perspectives
- Chapter 3. Biopolymers for in situ–forming hydrogels, synthesis, characterization, toxicity issues, and application
- 3.1. Introduction
- 3.2. Natural and partially synthetic derived polymers
- 3.3. Synthetic polymeric matrices
- 3.4. Characterization
- 3.5. Evaluating the tolerance of ophthalmic gels for the eyes
- 3.6. Toxicity issues
- 3.7. Applications
- 3.8. Recent advances and emerging trends in in situ gelling polymeric hydrogels
- 3.9. Challenges and future prospect
- 3.10. Conclusions along with viewpoints
- Chapter 4. Biopolymer stimuli-responsive in situ hydrogels, chemistry, and their potential applications in ODDS
- 4.1. Introduction
- 4.2. Biopolymer stimuli-responsive in situ gels
- 4.3. Chemistry of biopolymer stimuli-responsive in situ hydrogels
- 4.4. Ionically triggered polymeric matrices
- 4.5. Potential applications of biopolymer stimuli-responsive in situ hydrogels in ophthalmology
- 4.6. Conclusion
- Chapter 5. Fabrication of biopolymer in situ–forming hydrogels
- 5.1. Introduction
- 5.2. Preparation of in situ–forming polymeric hydrogels
- 5.3. Challenges
- 5.4. Conclusions and future prospects
- Chapter 6. Modeling: Process optimization for design, engineering, and fabrication of biopolymer in situ–forming hydrogels
- 6.1. Introduction
- 6.2. Designed/optimization of in situ–forming hydrogels
- 6.3. Challenges and suggested way forward
- 6.4. Conclusions
- Chapter 7. Properties of biopolymeric in situ hydrogel-based biomaterials
- 7.1. Introduction
- 7.2. Conclusion
- Chapter 8. Swelling and drug release kinetics of biopolymer in situ–forming hydrogels for ophthalmic drug delivery
- 8.1. Introduction
- 8.2. Swelling and drug release kinetics of biopolymer in situ–forming hydrogels for ophthalmic drug delivery
- 8.3. Conclusion
- Chapter 9. Structural load-bearing characteristics of biopolymer in situ–forming hydrogels for ophthalmic drug delivery
- 9.1. Introduction
- 9.2. Structural characteristic
- 9.3. Load-bearing
- 9.4. Implications of structural load-bearing properties in the context of ophthalmic drug delivery of biopolymer in situ–forming hydrogels
- 9.5. Challenges and way forward
- 9.6. Conclusion
- Chapter 10. Functionalization and its effect on the properties of in situ–forming biopolymer hydrogels
- 10.1. Introduction
- 10.2. Functionalization and its effect on the properties of in situ–forming biopolymer hydrogels
- 10.3. Conclusion and future outlook
- Chapter 11. Application of biopolymer in situ–forming hydrogels in ophthalmic drug delivery system and others
- 11.1. Introduction
- 11.2. General biopolymeric in situ–forming hydrogels application areas
- 11.3. Applications beyond ophthalmology
- 11.4. Summary and perspective
- Part II. Applications of biopolymers in situ-forming hydrogels for ophthalmic drug delivery
- Chapter 12. Eye anatomy, physiology, and ocular barriers
- 12.1. Introduction
- 12.2. Eye anatomy and ocular structures
- 12.3. Physiology of the eye
- 12.4. Ophthalmic pharmacokinetics
- 12.5. Barriers to ophthalmic drug delivery
- 12.6. Absorption pathways, both corneal and noncorneal
- 12.7. Ocular medication administration route
- 12.8. Barriers to in situ–forming OP DDS
- 12.9. Recent approaches adopted in in situ–forming hydrogels for overcoming ocular barriers to effective drug delivery
- 12.10. Conclusion
- Chapter 13. Models/techniques to evaluate ophthalmic drug delivery formulations
- 13.1. Introduction
- 13.2. In vitro and in vivo models/techniques to evaluate ophthalmic drug delivery formulations
- 13.3. Emerging technologies and cutting-edge methodologies
- 13.4. Conclusions
- Chapter 14. Formulation/design concepts based on the features/barriers of ocular drug deliveries
- 14.1. Introduction
- 14.2. Formulation/design concepts based on the features/barriers of the different ocular drug delivery routes (e.g., topical, transscleral, suprachoroidal, etc.)
- 14.3. Conclusion
- Chapter 15. Clinical indications that need a thermoresponsive hydrogel
- 15.1. Introduction
- 15.2. Clinical indications that need a thermoresponsive hydrogel
- 15.3. Obstacles and way forward
- 15.4. Conclusion
- Chapter 16. An overview on materials/polymers suitable for stimuli-responsive hydrogels: Natural or synthetic
- 16.1. Introduction
- 16.2. Carbohydrates
- 16.3. Poly(N-isopropylacrylamide) copolymers
- 16.4. Poloxamer systems (Fig. 16.3)
- 16.5. Poly(ethylene oxide)/poly(d,l-lactic acid-co-glycolic acid)
- 16.6. Liposomes that are thermosensitive operate as a physical barrier between reactive species
- 16.7. Others
- 16.8. Emerging trends and future prospects
- 16.9. Conclusion
- Chapter 17. Viscoelastic characteristics and gelation kinetics of in situ–forming hydrogels
- 17.1. Introduction
- 17.2. Viscoelastic characteristics of in situ–forming hydrogels
- 17.3. Gelation kinetics of in situ–forming hydrogels
- 17.4. Challenges
- 17.5. Future prospects
- 17.6. Conclusion
- Chapter 18. Degradation kinetics of in situ–forming hydrogels
- 18.1. Introduction
- 18.2. Degradation kinetics of in situ–forming hydrogels
- 18.3. Challenges associated with in situ–forming hydrogel degradation
- 18.4. Conclusion
- Chapter 19. Cell-laden stimuli-responsive hydrogels, their fabrication, and application
- 19.1. Introduction
- 19.2. Cell-laden in situ–forming biopolymeric hydrogels
- 19.3. Instances of cell-laden hydrogels as per literature
- 19.4. In vivo optical sensing
- 19.5. Final thoughts and opinions
- Chapter 20. Animal models and preclinical tests to evaluate in situ–forming hydrogels
- 20.1. Introduction
- 20.2. Animal models and preclinical trial
- 20.3. Challenges
- 20.4. Challenges and ways forward
- 20.5. Conclusions
- Chapter 21. Biopolymer-based in situ–forming hydrogels: From laboratory to practical application
- 21.1. Introduction
- 21.2. Laboratory research
- 21.3. Clinical/practical application
- 21.4. Regulatory aspects
- 21.5. Challenges and suggestions for scaling up in situ–forming hydrogels
- 21.6. Conclusion
- Chapter 22. Commercially available in situ gelling hydrogels for biomedical applications
- 22.1. Introduction
- 22.2. Challenges and considerations
- 22.3. Conclusion
- Chapter 23. Challenges, suggestive way out, and future of perspective of biopolymer in situ hydrogels in biomedical applications
- 23.1. General introduction
- 23.2. Summary of the challenges, suggested solutions, and the future of biopolymer in situ hydrogels in biomedical applications
- Chapter 24. Patents for biopolymer in situ–forming hydrogels for ophthalmic drug delivery and tissue regeneration
- 24.1. Introduction
- 24.2. Patents for biopolymer in situ–forming hydrogels from ophthalmic drug delivery
- 24.3. Present as well as forthcoming advancements
- 24.4. Challenges and way forward
- 24.5. Conclusion
- References
- Index
- Edition: 1
- Published: May 8, 2024
- No. of pages (Paperback): 672
- No. of pages (eBook): 500
- Imprint: Woodhead Publishing
- Language: English
- Paperback ISBN: 9780323991568
- eBook ISBN: 9780323993593
DC
Dipankar Chattopadhyay
JO
Jonathan Tersur Orasugh
Dr. Jonathan Tersur Orasugh is currently a postdoctoral researcher at the Department of Chemical Sciences, University of Johannesburg, Doornfontein 2028, Johannesburg, South Africa, and Centre for Nanostructures and Advanced Materials, DSI-CSIR Nanotechnology Innovation Centre, Council for Scientific & Industrial Research, CSIR, Pretoria 0001, South Africa. His research focus is in nanoscience and nanotechnology, Textiles, and Fibres. Presently, Dr. Jonathan is working on EMI shielding materials design and fabrication at CSIR, Pretoria in affiliation with the University of Johannesburg. He has also, carried out successful research work on synthesis of nano crystalline cellulose and its application in edible packaging, transdermal and ophthalmic drug delivery, and published articles in reputed high impact factor scientific journals along with several, presentation at international conferences. Dr. Jonathan has Ph.D. (Nanoscience and Nanotechnology) and MTech (Technical Textiles: Fibre Technology) from University of Calcutta, Kolkata, and B.Tech. (Textile Technology) from Kaduna Polytechnic, Kaduna, Nigeria. He has published more than 10 research articles in diverse international journals along with several books and book chapters with publishers of high repute. He is an active editor with few international journals and a reviewer with different international journals. He has more than 7yrs of research experience in the field of polymer composites and nanocomposites, synthesis, and surface treatment of nanomaterials along with their potential applications. He has carried out industrial-based research at to a satisfactory and implementable stage at the pilot plant scale. He is also an executive board member and research head at EL-YOTEK NIG. LTD. He is also a research consultant with AMER-SIL KETEX PVT LTD., India.
AA
Anjan Adhikari
SR